The decline of invasive meningococcal disease and influenza in the time of COVID-19: the silver linings of the pandemic playbook
Med J Aust
.
2022 Jun 6;216(10):504-507.
doi: 10.5694/mja2.51463.
Epub 2022 Mar 27.
Authors
Cr Robert George
1
,
Robert Booy
2
,
Michael D Nissen
3
4
,
Monica M Lahra
5
6
Affiliations
1
NSW Health Pathology, John Hunter Hospital, Newcastle, NSW.
2
University of Sydney, Sydney, NSW.
3
Children's Health Research Centre, University of Queensland, Brisbane, QLD.
4
University of Queensland, Brisbane, QLD.
5
NSW Health Pathology, Prince of Wales Hospital, Sydney, NSW.
6
University of New South Wales, Sydney, NSW.
PMID:
35340025
PMCID:
PMC9114995
DOI:
10.5694/mja2.51463
No abstract available
Keywords:
COVID-19; Influenza; Vaccine preventable disease.
MeSH terms
COVID-19*
Humans
Influenza Vaccines*
Influenza, Human* / epidemiology
Meningococcal Infections* / epidemiology
Pandemics
SARS-CoV-2
Vaccination
Substances
Influenza Vaccines